No improvement in cognition with post-menopausal hormones

2015-06-02

(Press-News.org) Menopausal hormone therapy (MHT) given to recently postmenopausal women in the US for up to four years does not improve cognition, but may have some positive benefits for some mood symptoms, according to a study published by Carey Gleason and colleagues from the University of Wisconsin, Madison, USA, in this week's PLOS Medicine.

The researchers reached these conclusions by conducting a randomized placebo-controlled clinical trial (the KEEPS-Cog trial), including 693 recently postmenopausal women living in the US who were randomly assigned to receive either oral estrogen pills and progesterone, or transdermal estradiol patches and progesterone, or placebo pills and patches. Over 4 years of follow-up, the researchers found no beneficial effects of treatment on cognition or on symptoms of clinical depression. However, women treated with oral estrogen pills and progesterone (but not those treated with transdermal estradiol patches and progesterone) showed improvements in some mood symptoms, as measured by the Profile of Mood States instrument, compared to women in the placebo group.

Importantly, these findings provide no information about the effects of MHT beyond 4 years and, because most of the women in the study were white, well-educated and at low risk of cardiovascular disease, may not be applicable to the general postmenopausal population of the US and of other countries. Moreover, because MHT improved menopausal symptoms in the women receiving hormones, the trial was not truly double-blinded. However, despite these and other study limitations, the researchers suggest that their findings could now be used to help women make more informed decisions about whether to use MHT to manage their menopausal symptoms.

The authors say: "Overall, the KEEPS-Cog findings provide valuable information to women considering the various options for managing menopausal symptoms."

INFORMATION:

Research Article

Funding: The KEEPS-Cog project was supported by grants from the National Institutes of Health (NIH) R01 AG029624, P50AG033514, R01AG031790, grant 1UL1RR025011 from the Clinical and Translational Science Award (CTSA) program of the NIH National Center for Research Resources and the Wisconsin National Primate Research Center base grant, NIH NCRR000167. The Parent KEEPS trial was funded by grants from the Aurora Foundation to the Kronos Longevity Research Institute, National Institutes of Health (NIH) HL90639 to VMM, Einstein College of Medicine, CTSA UL1 RR025750, KL2 RR025749 and TL1 RR025748, Mayo CTSA 1 UL1 RR024150, the Mayo Foundation, Brigham and Women's Hospital/Harvard Medical School CTSA, CTSA UL1 RR024139 and UCSF CTSA UL1 RR024131 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. Additional support provided by resources and facilities of the Madison VA, and the VA Puget Sound Health Care System. The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official view of NCATS or NIH. Information on NCATS is available at http://www.ncats.nih.gov. Bayer HealthCare Pharmaceuticals, Inc. supplied the CLIMARA estradiol and placebo patches and Abbott Laboratories (formerly Solvay Pharmaceuticals) provided the micronized progesterone (PROMETRIUM) and placebo capsules. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: MIC declared: I have research funding from Nora Therapeutics and Ferring pharmaceuticals. I am a member of ASRM Executive Board. NFS declared: 1. Menogenix: stock options (this is a company that has patented a novel non hormonal treatment for menopausal hot flashes and to date I have not exercised my stock options but would rather report this than give the appearance of not disclosing sufficient information). 2. Bayer, Inc: grant support (this is an investigator initiated grant that is supported by funds given to my institution. I receive no personal funds for this work). SA declared: 1) NIH Grants to support my research--NIA P50 Center Grant to support the Wisconsin Alzheimer's Disease Research Center (ADRC). 2) NIA T32 Training Grant in the Biology of Aging and Age-Related Diseases. 3) NIA RO1 that supported the KEEPS Cognitive and Affective Study. 4) Following Pharma Industry-supported research grants to serve as a site PI to conduct treatment trials in patients with Alzheimer's disease and Mild Cognitive Impairment (MCI): Merck Sharp and Dohme; H. Lundbeck A-S; Toyama Chemical Company. 5) Rockpointe Corporation--I am on the Speaker's Bureau of this science-based education corporation that sponsors CME-accredited education programs. My presentations are on Alzheimer's disease and not related to the focus of the manuscript under review. HST declared: I have served as a consultant to Bayer, Abbvie, Pfizer and Theraputics MD. My University has received grant support toward my work from Pfizer. I have authored papers with employees of Pfizer and Shionogi.

Citation: Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, et al. (2015) Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med 12(6): e1001833. doi:10.1371/journal.pmed.1001833

Author Affiliations:

School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin
Geriatric Research, Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin
Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin
Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin
Department of Neurology, Emory University School of Medicine, Atlanta, Georgia
Emory Alzheimer's Disease Research Center, Atlanta, Georgia
Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
Departments of Surgery and Physiology & Biomedical Engineering, Mayo Clinic, Rochester, Minnesota
Utah Foundation for Biomedical Research, Salt Lake City, Utah, United States of America
Obstetrics & Gynecology, University of California at San Francisco, San Francisco, California
Obstetrics & Gynecology, Columbia University College of Physicians and Surgeons, New York
VA Puget Sound Health Care System, Tacoma, Washington
Division of Metabolism, Endocrinology and Nutrition, University of Washington, Tacoma, Washington
Neuroscience and Obstetrics & Gynecology, Albert Einstein College of Medicine, Bronx, New York
Obstetrics & Gynecology, University of Colorado School of Medicine, Aurora, Colorado
Obstetrics & Gynecology, Yale University School of Medicine, New Haven, Connecticut
Epidemiology & Biostatistics, University of California at San Francisco, San Francisco, California
Division of Cardiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California
Atherosclerosis Research Unit, University of Southern California, Los Angeles, California
Obstetrics & Gynecology, New York University School of Medicine, New York, New York
Kronos Longevity Research Institute, Phoenix, Arizona
Division of Endocrinology, Phoenix VA Medical Center, Phoenix, Arizona

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001833

Contact:

Dr Carey E. Gleason
ceg@medicine.wisc.edu

ELSE PRESS RELEASES FROM THIS DATE:

How to weigh the Milky Way

2015-06-02

What if your doctor told you that your weight is somewhere between 100 and 400 lbs.? With any ordinary scale every patient can do better at home. Yet, one patient can't: the Milky Way. Even though today we peer deeper into space than ever before, our home galaxy's weight is still unknown to about a factor of four. Researchers at Columbia University's Astronomy Department have now developed a new method to give the Milky Way a more precise physical checkup. The Milky Way consists of roughly 100 billion stars that form a huge stellar disk with a diameter of 100-200 thousand ...

'Master controller' behind DNA structure reorganization during senescence identified

2015-06-02

PHILADELPHIA--(June 2, 2015)--Senescence, a phenomenon in which cells cease to divide and grow, can be caused by everything from natural DNA damage to treatment with chemotherapy. However, several mechanisms allow for cells to bypass senescence and grow out of control, eventually becoming cancerous. Now, scientists at The Wistar Institute have identified how a specific variant of a key protein complex found in human cells called condensin can reorganize a cell's genetic architecture in such a way as to promote senescence, making it an important facilitator in a cell's ...

Mass. General team develops transplantable bioengineered forelimb in an animal model

2015-06-02

A team of Massachusetts General Hospital (MGH) investigators has made the first steps towards development of bioartificial replacement limbs suitable for transplantation. In their report, which has been published online in the journal Biomaterials, the researchers describe using an experimental approach previously used to build bioartificial organs to engineer rat forelimbs with functioning vascular and muscle tissue. They also provided evidence that the same approach could be applied to the limbs of primates "The composite nature of our limbs makes building a functional ...

UF study shows benefits of multi-tasking on exercise

2015-06-02

Who says you can't do two things at once and do them both well? A new University of Florida study challenges the notion that multi-tasking causes one or both activities to suffer. In a study of older adults who completed cognitive tasks while cycling on a stationary bike, UF researchers found that participants' cycling speed improved while multi-tasking with no cost to their cognitive performance. Results of the study, which was supported by a grant from the National Institute on Aging, were published May 13 in the journal PLOS ONE. The discovery was a surprise finding ...

Why the 'cool factor' won't lure college grads to your city

2015-06-02

COLUMBUS, Ohio - A new nationwide study reveals that the kind of cities that attract college graduates has changed since the 1990s. In the 1990s, grads were moving to cities with fast-growing "smart" industries in fields like high tech, the study found. But since 2000, with a less vibrant national economy, college graduates are flocking toward the biggest cities with the biggest labor markets and the best chances of landing a job. In fact, the effect of city population size in attracting college grads was nearly four times as large in the 2000s as it was in the 1990s, ...

Amount of time New Yorkers spend sitting around far exceeds healthy levels

2015-06-02

(New York, NY, June 1, 2015)-- The Big Apple is one of the most walkable cities in the nation, providing many opportunities for physical activity, and New Yorkers are more likely to exercise regularly than the average U.S. adult. But they are also sitting far more than what is considered healthy. According to a new study published by the U.S. Centers for Disease Control and Prevention in its journal Preventing Chronic Disease, the average New York City resident sits more than seven hours a day--greatly exceeding the three hours or more per day that is associated with ...

New report: Texas Hispanics, women show largest reductions in rates of uninsured

2015-06-02

HOUSTON - (June 2, 2015) - Hispanics and women in Texas showed the largest percentage of reductions in rates of uninsured since enrollment began in the Affordable Care Act's (ACA) Health Insurance Marketplace, according to a new report released today by the Episcopal Health Foundation and Rice University's Baker Institute for Public Policy. The report found that from September 2013 to March 2015, the percentage of Hispanics without health insurance fell 38 percent (from 39.1 percent uninsured to 24.3 percent), more than any other ethnic group. The percentage of uninsured ...

Hyperbaric hope for fibromyalgia sufferers

2015-06-02

HOUSTON - (June 2, 2015) - Women who suffer from fibromyalgia benefit from a treatment regimen in a hyperbaric oxygen chamber, according to researchers at Rice University and institutes in Israel. A clinical trial involving women diagnosed with fibromyalgia showed the painful condition improved in every one of the 48 who completed two months of hyperbaric oxygen therapy. Brain scans of the women before and after treatment gave credence to the theory that abnormal conditions in pain-related areas of the brain may be responsible for the syndrome. Results of the study ...

Study explores how past Native-American settlement modified Western New York forests

2015-06-02

BUFFALO, N.Y. -- A new study by University at Buffalo geographers explores how humans altered the arboreal make-up of Western New York forests before European settlers arrived in large numbers. The research looked at land survey data from around 1799-1814, and used this information to model which tree species were present in different areas of Chautauqua County, New York, at that time. The analysis placed hickory, chestnut and oak trees in larger-than-expected numbers near the historical sites of Native American villages, said co-author Steve Tulowiecki, who conducted ...

Reflection in medical education can lead to less burn-out

2015-06-02

MAYWOOD, Ill. - Drawing on its Jesuit Catholic heritage, Loyola University Chicago Stritch School of Medicine has long understood the importance of reflection in medical education as a key element in physician formation. With physician burnout on the rise, it is all the more integral for students to learn ways to engage better with the challenges faced in the medical profession. Stritch faculty members believe reflection is a fundamental tool to help students process and cope with the tremendous physical, emotional, and mental pressure that can accompany their vocation. These ...

No improvement in cognition with post-menopausal hormones

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: